D2 Striatal Medium Spiny Neurons in Parkinson's Disease

D2 Striatal Medium Spiny Neurons in Parkinson's Disease

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">D2 Striatal Medium Spiny Neurons in Parkinson's Disease</th>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4030047](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4030047)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4030049](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4030049)</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:4030047](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4030047)</td>
</tr>
</table>

D2 Striatal Medium Spiny Neurons In Parkinson'S Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.

Overview

D2 Striatal Medium Spiny Neurons in Parkinson's Disease

Introduction

<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">D2 Striatal Medium Spiny Neurons in Parkinson's Disease</th>
</tr>
<tr>
<td class="label">Database</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4030047](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4030047)</td>
</tr>
<tr>
<td class="label">Cell Ontology</td>
<td>[CL:4030049](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4030049)</td>
</tr>
<tr>
<td class="label">Taxonomy</td>
<td>ID</td>
</tr>
<tr>
<td class="label">Cell Ontology (CL)</td>
<td>[CL:4030047](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4030047)</td>
</tr>
</table>

D2 Striatal Medium Spiny Neurons In Parkinson'S Disease is a cell type relevant to neurodegenerative disease research. This page covers its role in brain function, involvement in disease processes, and significance for therapeutic strategies.

Overview

D2-expressing medium spiny neurons (D2-MSNs) in the striatum are a key population affected in Parkinson's disease. These neurons form the indirect pathway and their dysfunction contributes to the motor and non-motor manifestations of PD. [@gerfen2011]

<!-- multi-taxonomy-enrichment --> [@kreitzer2008]

<!-- taxonomy-enrichment --> [@picconi2003]

Taxonomy & Classification

External Database Links

• [Cell Ontology (CL:4030047)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4030047)
• [OBO Foundry (CL:4030047)](http://purl.obolibrary.org/obo/CL_4030047)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)

Multi-Taxonomy Classification

Taxonomy Database Cross-References

Morphology & Electrophysiology

• Morphology: matrix D2 medium spiny neuron (source: Cell Ontology)
• Morphology can be inferred from Cell Ontology classification

External Database Links

• [Cell Ontology (CL:4030047)](https://www.ebi.ac.uk/ols4/ontologies/cl/classes/http%253A%252F%252Fpurl.obolibrary.org%252Fobo%252FCL_4030047)
• [OBO Foundry (CL:4030047)](http://purl.obolibrary.org/obo/CL_4030047)
• [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas)
• [CellxGene Census](https://cellxgene.cziscience.com/)
• [Human Cell Atlas](https://www.humancellatlas.org/)

Striatal Organization

Direct vs. Indirect Pathways

Direct Pathway (D1-MSNs): facilitates movement
Motor cortex → Striatum (D1) → GPi/SNr → Thalamus → Cortex

Indirect Pathway (D2-MSNs): suppresses movement
Motor cortex → Striatum (D2) → GPe → STN → GPi/SNr → Thalamus → Cortex

D2-MSN Characteristics

• Express D2 dopamine receptors
• Project to globus pallidus externus (GPe)
• Indirect pathway for movement suppression
• Co-express adenosine A2A receptors

Changes in Parkinson's Disease

Pathophysiological Cascade

Electrophysiological Changes

• Increased firing rate in D2-MSNs
• Burst firing patterns
• Altered plateau potentials
• Reducedpacemaker fidelity

Molecular Mechanisms

Dopamine Signaling

• Loss of tonic dopamine → D2 receptor supersensitivity
• Up-regulated D2R expression (compensatory)
• Altered D2R signaling (β-arrestin pathway)

Intracellular Pathways

D2R activation → Gi/o protein →
↓ cAMP → PKA inhibition →
↓ DARPP-32 → PP1 activation →
Enhanced indirect pathway activity

Gene Expression Changes

• DRD2 upregulation
• Adenosine A2A receptor changes
• CB1 receptor alterations
• Synaptic plasticity gene dysregulation

Therapeutic Implications

Dopaminergic Therapy

• Levodopa: Reduces D2-MSN overactivity
• D2 agonists: Direct stimulation
• Response complications: Dyskinesias from D1/D2 imbalance

A2A Antagonism

• Istradefylline: A2A antagonist
• Selectively reduces D2-MSN activity
• Motor improvement without dyskinesias

Deep Brain Stimulation

• STN-DBS: Reduces indirect pathway output
• GPi-DBS: Normalizes output directly
• Effects on D2-MSNs indirect

Non-Motor Symptoms

Cognitive Effects

• Working memory deficits
• Habit learning impairment
• Goal-directed behavior disruption

Affective Symptoms

• Depression comorbidity
• Anhedonia contribution
• Anxiety association

Background

The study of D2 Striatal Medium Spiny Neurons In Parkinson'S Disease has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

• [Parkinson's Disease](/diseases/parkinsons-disease)
• [/mechanisms/alpha-synuclein](/mechanisms/alpha-synuclein-aggregation-pathway)
• [Synaptic Dysfunction](/mechanisms/synaptic-dysfunction)
• [NMDA](/entities/nmda-receptor)
• /diseases

External Links

• [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
• [Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
• [Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data

Cross-References

• [D2 Dopamine Receptor](/proteins/d2-dopamine-receptor)
• [Striatal Medium Spiny Neurons](/cell-types/striatal-medium-spiny-neurons)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Indirect Pathway](/cell-types/striatal-indirect-pathway-medium-spiny-neurons)
• [Basal Ganglia](/brain-regions/basal-ganglia)
• [Dyskinesias in Parkinson's Disease](/symptoms/dyskinesias-parkinsons)
• [Adenosine A2A Receptor](/entities/adenosine-a2a-receptor)

See Also

• [Prefrontal Cortex Neurons in Alzheimer's Disease](/wiki/cell-types-prefrontal-cortex-neurons-in-alzheimers-disease) — associated_with
• [SNCA — Alpha-Synuclein](/wiki/genes-snca) — causes
• [ASO-Tau Reduction](/wiki/therapeutics-aso-tau-reduction) — treats
• [A53T Alpha-Synuclein Transgenic Mouse Model of Parkinson's Disease](/wiki/models-a53t-alpha-synuclein-mouse-parkinsons) — causes
• [C3 — Complement Component 3](/wiki/genes-c3) — contributes_to
• [Spinal Trigeminal Nucleus in Neurodegeneration](/wiki/cell-types-spinal-trigeminal-nucleus-neurodegeneration) — contributes_to

Pathway Diagram

The following diagram shows the key molecular relationships involving D2 Striatal Medium Spiny Neurons in Parkinson's Disease discovered through SciDEX knowledge graph analysis: